Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6434067 | 0.95 | PYGM (0.62) | PYGMPYGL | |
| SCHEMBL6431989 | 0.93 | PYGL (0.76) | PYGMPYGL | |
| SCHEMBL6434074 | 0.89 | PYGM (0.64) | PYGMPYGL | |
| SCHEMBL7199970 | 0.88 | PYGL (0.86) | PYGMPYGL | |
| SCHEMBL6430901 | 0.86 | PYGM (0.67) | PYGMPYGL | |
| SCHEMBL6432820 | 0.83 | PYGM (0.80) | PYGMPYGL | |
| SCHEMBL6436695 | 0.83 | PYGM (0.64) | PYGMPYGL | |
| SCHEMBL6431628 | 0.83 | PYGM (0.64) | PYGMPYGL | |
| SCHEMBL6431624 | 0.83 | PYGM (0.78) | PYGMPYGL | |
| SCHEMBL6431378 | 0.83 | PYGM (1.00) | PYGMPYGL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6590118-B1 | Used in treatment of and/or prevention of diabetes, especially non-insulin dependent diabetes (Type 2 diabetes) | NOVO NORDISK A/S (DK) | 2003-07-08 | — | — | US | disclosed |